| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 103,115,782 | 121,228,623 | 94,240,690 | | Cost of Revenue | 76,421,695 | 86,286,017 | 66,853,707 | | | Gross Profit | 26,694,088 | 34,942,606 | 27,386,983 | | | Operating Expenses | | Research Development | 5,800,929 | 5,938,386 | 4,690,700 | | Selling General and Administrative | 18,939,836 | 19,377,820 | 15,455,312 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 1,953,323 | 9,626,401 | 7,240,972 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (55,270) | (410,515) | (391,842) | | Earnings Before Interest And Taxes | 1,898,053 | 9,215,886 | 6,849,130 | | Interest Expense | 232,193 | 167,892 | 109,752 | | Income Before Tax | 1,665,860 | 9,047,994 | 6,739,378 | | Income Tax Expense | 1,131,301 | 3,913,104 | 2,412,691 | | Minority Interest | (143,458) | (275,811) | (170,995) | | | | Net Income From Continuing Ops | 1,411,152 | 6,060,394 | 5,034,737 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 1,411,152 | 6,060,394 | 5,034,737 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,411,152 | $6,060,394 | $5,034,737 |
|
0.16% Nasdaq 
Income Statement
